| __timestamp | Biogen Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 104381000 |
| Thursday, January 1, 2015 | 2012800000 | 100171000 |
| Friday, January 1, 2016 | 1973300000 | 102726000 |
| Sunday, January 1, 2017 | 2253600000 | 96171000 |
| Monday, January 1, 2018 | 2597200000 | 66449000 |
| Tuesday, January 1, 2019 | 2280600000 | 42672000 |
| Wednesday, January 1, 2020 | 3990900000 | 42534000 |
| Friday, January 1, 2021 | 2501200000 | 53311000 |
| Saturday, January 1, 2022 | 2231100000 | 82258000 |
| Sunday, January 1, 2023 | 2702600000 | 118011000 |
| Monday, January 1, 2024 | 2041800000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Biogen Inc. and Celldex Therapeutics, Inc. have showcased contrasting strategies in their R&D investments. From 2014 to 2023, Biogen's R&D expenses have consistently dwarfed those of Celldex, with Biogen's spending peaking in 2020 at nearly 400% more than its 2014 levels. In contrast, Celldex's R&D spending has remained relatively stable, with a modest increase of about 13% over the same period. This disparity highlights Biogen's aggressive pursuit of new therapies, while Celldex maintains a more conservative approach. As the biotech industry continues to evolve, these spending patterns may offer insights into each company's future growth and innovation potential.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
GSK plc or Biogen Inc.: Who Invests More in Innovation?
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
Analyzing R&D Budgets: Biogen Inc. vs Agios Pharmaceuticals, Inc.
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Genmab A/S vs Celldex Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
TG Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Mesoblast Limited and Celldex Therapeutics, Inc. Allocate Funds